This is not the most recent version of the article. View current version (18 NOV 2013)

Intervention Protocol

Quetiapine versus other atypical antipsychotics for schizophrenia

  1. Katja Komossa1,*,
  2. Heike Hunger1,
  3. Franziska Schmidt1,
  4. Sandra Schwarz1,
  5. Stefan Leucht1,
  6. Manit Srisurapanont2,
  7. Christine Rummel-Kluge1

Editorial Group: Cochrane Schizophrenia Group

Published Online: 18 JUL 2007

DOI: 10.1002/14651858.CD006625


How to Cite

Komossa K, Hunger H, Schmidt F, Schwarz S, Leucht S, Srisurapanont M, Rummel-Kluge C. Quetiapine versus other atypical antipsychotics for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006625. DOI: 10.1002/14651858.CD006625.

Author Information

  1. 1

    Technische Universität München Klinikum rechts der Isar, Klinik und Poliklinik für Psychiatrie und Psychotherapie, München, Germany

  2. 2

    Chiang Mai University, Department of Psychiatry, Chiang Mai 50202, Thailand

*Katja Komossa, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München Klinikum rechts der Isar, Moehlstrasse 26, München, 81675, Germany. k.komossa@lrz.tu-muenchen.de.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 18 JUL 2007

SEARCH

This is not the most recent version of the article. View current version (18 NOV 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To review the effects of quetiapine compared with other atypical antipsychotics for people with schizophrenia and schizophrenia-like psychosis.